The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Additionally, IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation (Gaffen et al., 2014).”
BackgroundSelf-citationNeutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
“In this mechanism, macrophages and also dendritic cells phagocytose apoptotic neutrophils (Gordy et al., 2011; Jiao et al., 2014) leading to a reduction on IL-23 (Stark et al., 2005), which in turn controls expression of IL-17 by T lymphocytes (Gaffen et al., 2014).”
BackgroundPathophysiology of Inflammatory Bowel Diseases
Chang, J. T. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2002697 · Cited by 1,295
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
“Th17 cells, induced by the cytokines IL-6, IL-1β, IL-21, TGF-β, and IL-23 present in synovial joints [48,49], were shown to recruit neutrophils, activate B cells, and promote osteoclastogenesis [50,51].”
BackgroundTeng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J.-L., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 873
Self-citationThe Balance of Th17 versus Treg Cells in Autoimmunity
Lee, G. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030730 · Cited by 857
Unraveling the Complex Interplay Between T Cell Metabolism and Function
Klein Geltink, R. I., Kyle, R. L., & Pearce, E. L. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053019 · Cited by 814
“immunity, but pathogenic Th17 cells, which make IFN-γ in addition to IL-17, are the cause of a number of inflammatory diseases (120).”
BackgroundIL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“Myeloid cells have also been reported to make IL-17, although not in large amounts, and in many cases the validity of this has been called into question [7].”
BackgroundSelf-citationThe gut microbiome as a major regulator of the gut-skin axis
Salem, I., Ramser, A., Isham, N., & Ghannoum, M. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01459 · Cited by 707
The cytokine network involved in the host immune response to periodontitis
Pan, W., Wang, Q., & Chen, Q. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0064-z · Cited by 696
Gordon, K. B., Strober, B., Lebwohl, M., Augustin, M., Blauvelt, A., Poulin, Y., Papp, K. A., Sofen, H., Puig, L., Foley, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31713-6 · Cited by 678
Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis
Kondo, N., Kuroda, T., & Kobayashi, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010922 · Cited by 680
“Furthermore, the number of osteoclasts induced ex vivo from RA patient PBMCs with TNF and IL-6 is positively correlated with the host patient modified total Sharp score [105].”
BackgroundNeutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 653
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Tie, Y., Tang, F., Wei, Y.-Q., & Wei, X.-W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01282-8 · Cited by 591
“For mechanisms, TANs inhibit the activation of T cells through secreting the Arg-1, ROS, and NO induced by G-CSF and TGF-β [12, 43].”
BackgroundInfluentialReich, K., Papp, K. A., Blauvelt, A., Tyring, S. K., Sinclair, R., Thaçi, D., Nograles, K., Mehta, A., Cichanowitz, N., Li, Q., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31279-5 · Cited by 569
The pathogenicity of Th17 cells in autoimmune diseases
Yasuda, K., Takeuchi, Y., & Hirota, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00733-8 · Cited by 555
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
Kortlever, R. M., Sodir, N. M., Wilson, C. H., Burkhart, D. L., Pellegrinet, L., Brown Swigart, L., Littlewood, T. D., & Evan, G. I. (2017) · Cell · doi:10.1016/j.cell.2017.11.013 · Cited by 553
“IL-23 is the principal trigger of TH17 lymphocytes, anROR1g-dependent T cell subset whose consequent secretion of IL-17 and IL-22 induces, in turn, production of diverse inflammatory cytokines, chemokines, and prostaglandins by many stromal cell types (Gaffen et al., 2014).”
BackgroundA brief history of T cell help to B cells
Crotty, S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3803 · Cited by 553
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Papp, K. A., Blauvelt, A., Bukhalo, M., Gooderham, M., Krueger, J. G., Lacour, J.-P., Menter, A., Philipp, S., Sofen, H., Tyring, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607017 · Cited by 514
“Benign, malignant, or unspecified neoplasm 1 (2) 2 (5) 0 0”
Drug development in the era of precision medicine
Dugger, S. A., Platt, A., & Goldstein, D. B. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.226 · Cited by 493
The Immunobiology of the Interleukin-12 Family: Room for Discovery
Tait Wojno, E. D., Hunter, C. A., & Stumhofer, J. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.011 · Cited by 482
“While we focus on the impact of IL-23 on T cells, it also affects innate cell populations, and the narrative that describes its role in different inflammatory diseases continues to evolve (Gaffen et al., 2014).”
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Moschen, A. R., Tilg, H., & Raine, T. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0084-8 · Cited by 473
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
Lee, J.-Y., Hall, J. A., Kroehling, L., Wu, L., Najar, T., Nguyen, H. H., Lin, W.-Y., Yeung, S. T., Silva, H. M., Li, D., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.026 · Cited by 466
Neutrophils in cancer: prognostic role and therapeutic strategies
Ocana, A., Nieto-Jiménez, C., Pandiella, A., & Templeton, A. J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0707-7 · Cited by 459
“However this approach has not reached yet the oncology field, but drugs targeting these cytokines are approved for the treatment of other medical conditions like psoriasis [41, 42].”
BackgroundThe IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“28,30 A recent study revealed that IL-17RD may be a subunit of IL-17A, but it does not bind to IL-17F.”
BackgroundKashem, S. W., Riedl, M. S., Yao, C., Honda, C. N., Vulchanova, L., & Kaplan, D. H. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.016 · Cited by 448
“IL-23 signaling plays a critical role against mucocutaneous candidiasis as shown by the fact that humans with IL-23R signaling defects are prone to CMC andmicewith IL-23 deficiencies are susceptible to oral and cutaneous candidiasis (Gaffen et al., 2014; Kagami et al., 2010; Smeekens et al., 2011).”
The IL-23-IL-17 axis in inflammatory arthritis
Lubberts, E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.53 · Cited by 442
Tan, T. G., Sefik, E., Geva-Zatorsky, N., Kua, L., Naskar, D., Teng, F., Pasman, L., Ortiz-Lopez, A., Jupp, R., Wu, H.-J. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617460113 · Cited by 427
“Elevated Th17 cell responses have been associated with autoimmune/inflammatory disease in both mice and humans (19, 20).”
InfluentialNakamoto, N., Sasaki, N., Aoki, R., Miyamoto, K., Suda, W., Teratani, T., Suzuki, T., Koda, Y., Chu, P.-S., Taniki, N., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0333-1 · Cited by 425
The influence of neuroinflammation in Autism Spectrum Disorder
Matta, S. M., Hill-Yardin, E. L., & Crack, P. J. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.04.037 · Cited by 416
Akkermansia muciniphila phospholipid induces homeostatic immune responses
Bae, M., Cassilly, C. D., Liu, X., Park, S.-M., Tusi, B. K., Chen, X., Kwon, J., Filipčík, P., Bolze, A. S., Liu, Z., et al. (2022) · Nature · doi:10.1038/s41586-022-04985-7 · Cited by 413
IL-17 in Chronic Inflammation: From Discovery to Targeting
Beringer, A., Noack, M., & Miossec, P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.001 · Cited by 402
The dichotomous nature of T helper 17 cells
Stockinger, B., & Omenetti, S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.50 · Cited by 402
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396
Baeten, D., Østergaard, M., Wei, J. C.-C., Sieper, J., Järvinen, P., Tam, L.-S., Salvarani, C., Kim, T.-H., Solinger, A., Datsenko, Y., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213328 · Cited by 390
“19 Although it is well characterised that one function of IL-23 is the induction and maintenance of Th17 cells, 15 it is likely that IL-23-independent sources of IL-17 are still active, such as IL-17-secreting mast cells and mucosal-associated invariant T cells.”
Baylor-Hopkins Center for Mendelian Genomics, Watkin, L. B., Jessen, B., Wiszniewski, W., Vece, T. J., Jan, M., Sha, Y., Thamsen, M., Santos-Cortez, R. L. P., Lee, K., et al. (2015) · Nature Genetics · doi:10.1038/ng.3279 · Cited by 388
Dutzan, N., Kajikawa, T., Abusleme, L., Greenwell-Wild, T., Zuazo, C. E., Ikeuchi, T., Brenchley, L., Abe, T., Hurabielle, C., Martin, D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0797 · Cited by 382
Wirthgen, E., Hoeflich, A., Rebl, A., & Günther, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01957 · Cited by 378
“The downregulation of the IL23/IL17 axis is known to be beneficial for anti-inflammatory treatment of many immune-mediated diseases (70).”
BackgroundMucosal immunity to pathogenic intestinal bacteria
Perez-Lopez, A., Behnsen, J., Nuccio, S.-P., & Raffatellu, M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.17 · Cited by 375
Baliwag, J., Barnes, D. H., & Johnston, A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.014 · Cited by 373
“Given the attractiveness of IL-17 as a therapeutic target in psoriasis, several more avenues are being explored, including inhibiting IL-17 signal transduction pathways [74] such as RORγt inverse agonists for inhibiting Th17-specific gene expression [75].”
BackgroundIL-17-producing γδ T cells enhance bone regeneration
Ono, T., Okamoto, K., Nakashima, T., Nitta, T., Hori, S., Iwakura, Y., & Takayanagi, H. (2016) · Nature Communications · doi:10.1038/ncomms10928 · Cited by 371
Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity
Cohen, J. A., Edwards, T. N., Liu, A. W., Hirai, T., Jones, M. R., Wu, J., Li, Y., Zhang, S., Ho, J., Davis, B. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.022 · Cited by 371
Interleukin-17 and innate immunity in infections and chronic inflammation
Isailovic, N., Daigo, K., Mantovani, A., & Selmi, C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.006 · Cited by 363
T cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 362
“IL-23 drives differentiation and functionality of Th17 cells (95), and an early report in mice found that knockout of the IL-23 subunit p19, which promotes the production of IL-17, resulted in almost complete loss of M.”
BackgroundRole of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
Intricacies of TGF-β signaling in Treg and Th17 cell biology
Wang, J., Zhao, X., & Wan, Y. Y. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01036-7 · Cited by 356
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
Baumgart, D. C., & Le Berre, C. (2021) · New England Journal of Medicine · doi:10.1056/nejmra1907607 · Cited by 354
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
Maxwell, J. R., Zhang, Y., Brown, W. A., Smith, C. L., Byrne, F. R., Fiorino, M., Stevens, E., Bigler, J., Davis, J. A., Rottman, J. B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.019 · Cited by 342
“Th17 cells are increased in Crohn’s disease patients and are a pathogenic cell type in various mouse disease models (Ahern et al., 2008, 2010; Gaffen et al., 2014; Khanna et al., 2014; Kleinschek et al., 2009).”
BackgroundInfluentialThe role of IL-17 in CNS diseases
Waisman, A., Hauptmann, J., & Regen, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1402-7 · Cited by 340
“There is an ample number of reviews summarizing this topic [16, 19–21, 34, 69, 88, 98] but for the sake of this particular review, we will briefly summarize the main points.”
BackgroundThe role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis
Girolomoni, G., Strohal, R., Puig, L., Bachelez, H., Barker, J., Boehncke, W. H., & Prinz, J. C. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14433 · Cited by 313
Venken, K., Jacques, P., Mortier, C., Labadia, M. E., Decruy, T., Coudenys, J., Hoyt, K., Wayne, A. L., Hughes, R., Turner, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07911-6 · Cited by 312
Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity
Leonardi, I., Gao, I. H., Lin, W.-Y., Allen, M., Li, X. V., Fiers, W. D., De Celie, M. B., Putzel, G. G., Yantiss, R. K., Johncilla, M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.017 · Cited by 307
Characterization of the human immune cell network at the gingival barrier
Dutzan, N., Konkel, J. E., Greenwell-Wild, T., & Moutsopoulos, N. M. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.136 · Cited by 305
“The cytokine IL-17 is considered a driving force of inflammatory bone loss, through the upregulation of RANKL and the activation of osteoclastogenesis as shown in arthritis and in animal models of periodontitis 20,47 .”
Selected cytokine pathways in rheumatoid arthritis
Noack, M., & Miossec, P. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0619-z · Cited by 303
“Such activation induces many inflammatory genes, mainly the neutrophil-specific chemokines [89, 250].”
BackgroundIL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301
“Whereas IL-17 activates TRAF/NF-kB signaling, IL-22 activates the JAK–STAT pathway, primarily STAT3 (43).”
BackgroundInfluentialSelf-citationCurrent Developments in the Immunology of Psoriasis.
Grän, F., Kerstan, A., Serfling, E., Goebeler, M., & Muhammad, K. (2020) · The Yale Journal of Biology and Medicine · Cited by 307
IL-12 Family Cytokines in Cancer and Immunotherapy
Mirlekar, B., & Pylayeva-Gupta, Y. (2021) · Cancers · doi:10.3390/cancers13020167 · Cited by 295
“IL-23R signaling in CD4+ T cells activates STAT3, which in turn stabilizes RORγt expression and enhances IL-17 gene transcription [63,64].”
BackgroundInfluentialMaverakis, E., Marzano, A. V., Le, S. T., Callen, J. P., Brüggen, M.-C., Guenova, E., Dissemond, J., Shinkai, K., & Langan, S. M. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0213-x · Cited by 285
Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy
Alam, J., Jantan, I., & Bukhari, S. N. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.055 · Cited by 280
Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease
Burberry, A., Suzuki, N., Wang, J.-Y., Moccia, R., Mordes, D. A., Stewart, M. H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6038 · Cited by 269
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044002 · Cited by 263
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
Verstockt, B., Salas, A., Sands, B. E., Abraham, C., Leibovitzh, H., Neurath, M. F., Vande Casteele, N., Alimentiv Translational Research Consortium (ATRC), Danese, S., D’Haens, G., et al. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00768-1 · Cited by 261
IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis
Faust, H. J., Zhang, H., Han, J., Wolf, M. T., Jeon, O. H., Sadtler, K., Peña, A. N., Chung, L., Maestas, D. R., Tam, A. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134091 · Cited by 260
C-type lectin receptors in the control of T helper cell differentiation
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.55 · Cited by 257
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Hammitzsch, A., Tallant, C., Fedorov, O., O’Mahony, A., Brennan, P. E., Hay, D. A., Martinez, F. O., Al-Mossawi, M. H., de Wit, J., Vecellio, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501956112 · Cited by 254
“CBP/p300 is thought to be involved at an early stage, consistent with our data showing key sensitivity of human IL 17A transcription to CBP/p300 inhibition (38, 39).”
BackgroundInterleukin-17 in chronic inflammatory neurological diseases
Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250
“Expression of IL-17R is ubiquitous, but the main targets of IL-17 are non-hematopoietic cells (23).”
BackgroundThe role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
Update on psoriasis immunopathogenesis and targeted immunotherapy
Mahil, S. K., Capon, F., & Barker, J. N. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-015-0539-8 · Cited by 245
“Subsequent exposure to IL-23 and IL-21 promotes the activation and proliferation of mature, inflammatory Th17 cells [65].”
BackgroundWithers, D. R., Hepworth, M. R., Wang, X., Mackley, E. C., Halford, E. E., Dutton, E. E., Marriott, C. L., Brucklacher-Waldert, V., Veldhoen, M., Kelsen, J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4046 · Cited by 243
β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
Kolbinger, F., Loesche, C., Valentin, M.-A., Jiang, X., Cheng, Y., Jarvis, P., Peters, T., Calonder, C., Bruin, G., Polus, F., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.038 · Cited by 238
“The IL-17 family of cytokines includes 6 members (IL-17A to IL-17F) that function as homodimers or heterodimers to signal through a family of cytokine receptors with multiple chains (IL-17RA to IL-17RE), with IL-17A and IL-17F signaling through a receptor complex composed of IL-17RA and IL-17RC.(2,3) Circulating level…”
BackgroundJaeger, N., Gamini, R., Cella, M., Schettini, J. L., Bugatti, M., Zhao, S., Rosadini, C. V., Esaulova, E., Di Luccia, B., Kinnett, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22164-6 · Cited by 237
Chemin, K., Gerstner, C., & Malmström, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00353 · Cited by 237
Sun, L., He, C., Nair, L., Yeung, J., & Egwuagu, C. E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.030 · Cited by 231
TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26
Meller, S., Di Domizio, J., Voo, K. S., Friedrich, H. C., Chamilos, G., Ganguly, D., Conrad, C., Gregorio, J., Le Roy, D., Roger, T., et al. (2015) · Nature Immunology · doi:10.1038/ni.3211 · Cited by 231
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
Marshall, E. A., Ng, K. W., Kung, S. H. Y., Conway, E. M., Martinez, V. D., Halvorsen, E. C., Rowbotham, D. A., Vucic, E. A., Plumb, A. W., Becker-Santos, D. D., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0551-1 · Cited by 231
Candidalysin: discovery and function in Candida albicans infections
Naglik, J. R., Gaffen, S. L., & Hube, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.06.002 · Cited by 229
Self-citationBoutet, M.-A., Nerviani, A., Gallo Afflitto, G., & Pitzalis, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020530 · Cited by 226
“Commonly, IL-23-activated Th17 cells trigger autoimmunity and chronic inflammation; conversely, TGFβ and IL-6 promote weakly pathogenic Th17 cells, important in tissue defence and integrity [62].”
BackgroundInfluentialPouring fuel on the fire: Th17 cells, the environment, and autoimmunity
Burkett, P. R., Meyer zu Horste, G., & Kuchroo, V. K. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78085 · Cited by 226
Calcinotto, A., Brevi, A., Chesi, M., Ferrarese, R., Garcia Perez, L., Grioni, M., Kumar, S., Garbitt, V. M., Sharik, M. E., Henderson, K. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07305-8 · Cited by 223
Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
Gravallese, E. M., & Schett, G. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0091-8 · Cited by 223
Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920928984 · Cited by 221
Reinhardt, A., Yevsa, T., Worbs, T., Lienenklaus, S., Sandrock, I., Oberdörfer, L., Korn, T., Weiss, S., Förster, R., & Prinz, I. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39732 · Cited by 219
Verma, A. H., Richardson, J. P., Zhou, C., Coleman, B. M., Moyes, D. L., Ho, J., Huppler, A. R., Ramani, K., McGeachy, M. J., Mufazalov, I. A., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam8834 · Cited by 218
Self-citationBlauvelt, A., Leonardi, C. L., Gooderham, M., Papp, K. A., Philipp, S., Wu, J. J., Igarashi, A., Flack, M., Geng, Z., Wu, T., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0723 · Cited by 217
“BSA involvement, median (IQR), % 19 (14-32) 23 (14-37) 19 (14-30) 20 (14-32)”
CRAC Channels and Calcium Signaling in T Cell-Mediated Immunity
Vaeth, M., Kahlfuss, S., & Feske, S. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.012 · Cited by 214
Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment
Fragoulis, G. E., Liava, C., Daoussis, D., Akriviadis, E., Garyfallos, A., & Dimitroulas, T. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i18.2162 · Cited by 213
Angelini, J., Talotta, R., Roncato, R., Fornasier, G., Barbiero, G., Dal Cin, L., Brancati, S., & Scaglione, F. (2020) · Biomolecules · doi:10.3390/biom10071002 · Cited by 213
“IL-23 Type I TYK2 JAK2 STAT3 STAT4 naïve T lymphocytes alopecia, rheumatoid arthritis, atopic dermatitis, systemic lupus erythematosus, ulcerative colitis, Crohn’s disease, ankylosing spondylitis [11,38,39,49,55]”
BackgroundCampanati, A., Marani, A., Martina, E., Diotallevi, F., Radi, G., & Offidani, A. (2021) · Biomedicines · doi:10.3390/biomedicines9111511 · Cited by 213
“Since IL-17 activates the IκB kinase (IKK)/NFκB pathway, inhibitory phosphorylation of IRS-1 directly by IKK and indirectly by JNK activation in response to other proinflammatory cytokines is able to attenuate insulin sensitivity [74].”
BackgroundWarren, R. B., Blauvelt, A., Poulin, Y., Beeck, S., Kelly, M., Wu, T., Geng, Z., & Paul, C. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19341 · Cited by 211
Revu, S., Wu, J., Henkel, M., Rittenhouse, N., Menk, A., Delgoffe, G. M., Poholek, A. C., & McGeachy, M. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.044 · Cited by 208
“Conversely, Th17 cells are important drivers of chronic inflammation in many autoimmune diseases (Gaffen et al., 2014).”
BackgroundLiu, L., Kikly, K., Lu, J., Allan, B., Tang, Y., Tetreault, J., Chow, C.-K., Barmettler, B., Nelson, J., Bina, H., et al. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s100940 · Cited by 208
Krebs, C. F., Paust, H.-J., Krohn, S., Koyro, T., Brix, S. R., Riedel, J.-H., Bartsch, P., Wiech, T., Meyer-Schwesinger, C., Huang, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.020 · Cited by 207
“Today, their central role in the pathogenesis of several autoimmune diseases is clearly established (Gaffen et al., 2014).”
BackgroundRole of the IL23/IL17 Pathway in Crohn’s Disease
Schmitt, H., Neurath, M. F., & Atreya, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622934 · Cited by 206
Li, H., Boulougoura, A., Endo, Y., & Tsokos, G. C. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102870 · Cited by 201
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
Fragoulis, G. E., Siebert, S., & McInnes, I. B. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051914-021944 · Cited by 201
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.